U.S. Markets closed

Houston oncology co. to merge with Boston’s struggling Flex Pharma

Olivia Pulsinelli
Houston oncology co. to merge with Boston’s struggling Flex Pharma

The announcement comes about seven months after Flex Pharma announced it would lay off most of its employees and explore a potential sale or merger after ending a mid-stage trial of its lead drug.